Secretome profiling of meningiomas: uncovering novel biomarkers for diagnostic applications

Meningiomas are the most common primary tumors of the central nervous system, traditionally diagnosed via imaging techniques. However, the need for molecular markers for risk stratification has garnered increasing attention. In this study, we employed secretome analysis to identify candidate proteins that could serve as diagnostic and prognostic markers for meningiomas.